| Date | Title | | | 12/14/12 | BioMed Realty Trust Declares Fourth Quarter 2012 Common Stock And Preferred Stock Dividends| Increases common stock dividend by 9.3%
SAN DIEGO, Dec. 14, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a fourth quarter 2012 dividend of $0.235 per share of common stock, representing a 9.3% increase over the company's third quarter 2012 dividend of $0.215 per share. The dividend is equivalent to an annualized dividend of $0.94 per common share.
BioMed Realty also announced that its board of direct... |
|  | | 11/09/12 | BioMed Realty To Audio Webcast Company Presentation At Investor Day 2012|
SAN DIEGO, Calif., Nov. 9, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) will audio webcast the company's presentation at its Investor Day 2012 to be held on Monday, November 12, 2012 at the Marriott Marquis in San Diego. The audio webcast will feature presentations by members of BioMed Realty's senior management team.
The live audio webcast will be broadcast through a link on BioMed Realty's website, www.biomedrealty.com, from approximately 4:00 p.m. to 5:15 p.m. Pacific Time... |
| | | 11/01/12 | BioMed Realty Trust Reports Third Quarter 2012 Financial Results| Year-over-year FFO and AFFO per share rise 13.3% and 10.0%, respectively
SAN DIEGO, Nov. 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust (REIT) that delivers optimal real estate solutions for the life science industry, today announced financial results for the third quarter ended September 30, 2012.
Third Quarter 2012 Highlights
Increased funds from operations (FFO) for the quarter by 13.3% to $0.34 per diluted share, as co... |
| | | 10/31/12 | BioMed Realty Announces 93,000 Square Foot Lease Expansion And Extension With Ironwood Pharmaceuticals At 301 Binney Street|
SAN DIEGO, Oct. 31, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the signing of an amendment to the lease with Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) at its 301 Binney Street facility in Cambridge, Massachusetts. As a result of this lease extension and phased expansion totaling approximately 93,000 square feet, Ironwood's occupancy in the five-story, state-of-the-art facility will increase to approximately 303,000 square feet. The term of the ... |
| | | 10/26/12 | BioMed Realty Announces 80,500 Square Foot Lease Expansion For Regeneron Pharmaceuticals| SAN DIEGO, Oct. 26, 2012 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has leased an additional 80,500 square feet of space at The Landmark at Eastview campus in Tarrytown, New York comprised of approximately 46,000 square feet of space in the 777 Building and approximately 34,500 square feet of space in the 765 Building.
Named as the world's top biopharmaceutical employer in a recent Science magazine survey... |
| | | 10/22/12 | BioMed Realty Trust To Report 2012 Third Quarter Results|
SAN DIEGO, Oct. 22, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its third quarter ended September 30, 2012 after the market closes on Thursday, November 1, 2012.
Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Friday, November 2, 2012 to discuss the ... |
| | | 09/14/12 | BioMed Realty Trust Declares Third Quarter 2012 Common Stock And Preferred Stock Dividends|
SAN DIEGO, Sept. 14, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a third quarter 2012 dividend of $0.215 per share of common stock. The dividend is equivalent to an annualized dividend of $0.86 per common share.
BioMed Realty also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from July 16, 2012 t... |
| | | 08/21/12 | Senior Leaders At BioMed Realty Recognized| Karen Sztraicher Promoted to Executive Vice President, Asset Management; Jonathan Klassen Promoted to General Counsel
SAN DIEGO, Aug. 21, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the promotion of Karen A. Sztraicher to Executive Vice President, Asset Management and Jonathan P. Klassen to Senior Vice President and General Counsel.
Alan D. Gold, Chairman and Chief Executive Officer of BioMed Realty, remarked, "I am very pleased to announce the... |
| | | 08/08/12 | BioMed Realty Announces New Brand Identity|
SAN DIEGO, Aug. 8, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today unveiled a new brand identity that highlights the company's commitment to the life science industry by delivering state-of-the-art laboratories and office spaces to meet the unique needs of its tenants. The brand identity features an energetic new look comprised of a monogram logo in the stylized shape of the company's initials and NYSE ticker symbol, BMR, and a new tagline, Discover here™.
"Bio... |
| | | 08/02/12 | BioMed Realty Trust Converts $156.4 Million Of Its Senior Unsecured Term Loan To 100 Million Pounds Sterling|
SAN DIEGO, Aug. 2, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has closed on an amendment to its senior unsecured term loan facility which converts $156.4 million of the $400 million principal amount outstanding to 100 million pounds sterling and provides for the base rate index on this portion of the facility to be GBP 1-month LIBOR. All other material terms and conditions of the term loan facility remain unchanged, including the interest rate m... |
| | | 08/01/12 | BioMed Realty Trust Reports Second Quarter 2012 Financial Results| Core FFO per share climbs 10.3% year-over-year to $0.32 per diluted share
SAN DIEGO, Aug. 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the second quarter ended June 30, 2012.
Second Quarter 2012 Highlights
Increased core funds from operations (CFFO) per share for the quarter by 10.3% to $0.32 per diluted share, as comp... |
| | | 07/24/12 | BioMed Realty Trust To Report 2012 Second Quarter Results|
SAN DIEGO, July 24, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its second quarter ended June 30, 2012 after the market closes on Wednesday, August 1, 2012.
Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 9:00 a.m. Pacific Time on Thursday, August 2, 2012 to discuss the compan... |
| | | 07/16/12 | 81,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty|
SAN DIEGO, July 16, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a lease extension with Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) for approximately 81,200 square feet at the company's Torreyana Road property located in the heart of the Torrey Pines submarket of San Diego, California. The lease now extends through December 31, 2018.
Ranked as the top place to work in the life science industry by Science magazine in 2011, Vertex has recei... |
| | | 06/28/12 | BioMed Realty, L.P. Announces Closing Of Offering Of 4.25% Senior Unsecured Notes Due 2022|
SAN DIEGO, June 28, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its operating partnership subsidiary, BioMed Realty, L.P., completed a public offering of $250 million aggregate principal amount of 4.25% Senior Notes due 2022 (the "Notes"). The Notes are senior unsecured obligations of the operating partnership and are fully and unconditionally guaranteed by BioMed Realty Trust, Inc.
Interest on the Notes is payable semiannually on January 15 and July 1... |
| | | 06/21/12 | BioMed Realty, L.P. Prices $250 Million Offering Of 4.25% Senior Unsecured Notes Due 2022|
SAN DIEGO, June 21, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its operating partnership subsidiary, BioMed Realty, L.P., priced a public offering of $250 million aggregate principal amount of 4.25% Senior Notes due 2022 (the "Notes"). The Notes were priced at 99.126% of the principal amount to yield 4.358% to maturity. The Notes will be senior unsecured obligations of the operating partnership and will be fully and unconditionally guaranteed by BioMed R... |
| | | 06/15/12 | BioMed Realty Trust Declares Second Quarter 2012 Common Stock And Preferred Stock Dividends|
SAN DIEGO, June 15, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a second quarter 2012 dividend of $0.215 per share of common stock. The dividend is equivalent to an annualized dividend of $0.86 per common share.
BioMed Realty also announced that its board of directors has declared a dividend of $0.46094 per share of the company's 7.375% Series A Cumulative Redeemable Preferred Stock for the period from April 16, 2012 ... |
| | | 06/11/12 | Biomed Realty To Acquire Granta Park In Cambridge, UK For 126.8 Million Pounds Sterling| Premier life science research park includes eleven buildings encompassing 472,200 square feet
SAN DIEGO, June 11, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement to acquire Granta Park, comprising eleven laboratory and office buildings and a total of approximately 472,200 square feet of space, as well as approximately 138,400 square feet of development and expansion rights, in Cambridge, United Kingdom. The purchase pr... |
| | | 06/11/12 | BioMed Realty Trust to Present at REITWeek 2012|
SAN DIEGO, June 11, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at REITWeek 2012: NAREIT's Investor Forum® in New York City on Wednesday, June 13, 2011 at approximately 8:00 a.m. Eastern Daylight Time.
A live webcast of the presentation will be available to all investors by accessing the company's website at www.biomedrealty.com. The complete webcast will be archived for 30 days.
About BioMed Realty Tru... |
| | | 06/11/12 | BioMed Realty Partners With Advanced BioHealing, A Subsidiary Of Shire plc, To Develop Regenerative Medicine Campus In San Diego|
SAN DIEGO, June 11, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has completed the acquisition of two parcels of land, comprising approximately 28 adjacent acres in San Diego, California for a purchase price of approximately $47 million, excluding transaction costs. Concurrently, the company has entered into a long-term ground lease for both sites with Advanced BioHealing, Inc. (ABH), a regenerative medicine company and a subsidiary of Shire plc, which dev... |
| | | 05/10/12 | New 126,000 Square Foot Lease at 650 East Kendall Street Signed By BioMed Realty|
SAN DIEGO, Calif., May 10, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) and AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced the signing of a new twelve-year lease for 126,000 square feet of laboratory and office space at 650 East Kendall Street, in the heart of the Kendall Square biotechnology super-cluster in Cambridge, Massachusetts. AVEO will move its headquarters and primary research facilities to the six-story, state-of-the-art multi-tenant research facility that i... |
| | | 05/01/12 | BioMed Realty Trust Reports First Quarter 2012 Financial Results| Strong Leasing Volume of 466,000 Square Feet; FFO guidance increased
SAN DIEGO, May 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the first quarter ended March 31, 2012.
First Quarter 2012 Highlights
Generated total revenues for the quarter of $120.0 million, up 14.1% from $105.2 million in the same period in 2011 and the highest in the ... |
| | | 04/24/12 | BioMed Realty Trust To Report 2012 First Quarter Results| SAN DIEGO, April 24, 2012 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its first quarter ended March 31, 2012 after the market closes on Tuesday, May 1, 2012.
Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Wednesday, May 2, 2012 to discuss the comp... |
| | | 04/16/12 | BioMed Realty Trust Introduces its 2011 Online Annual Report| SAN DIEGO, Calif., April 16, 2012 /PRNewswire via COMTEX/ --BioMed Realty Trust, Inc. (NYSE: BMR) announced today that its 2011 Online Annual Report and other proxy materials are now available at http://www.biomedrealty.com/11AR. BioMed Realty is posting its annual report in an online format following the SEC-approved electronic reporting guidelines for the fourth consecutive year.
The 2011 Online Annual Report, entitled "Creating Value," highlights the company's breakthrough operating and fi... |
| | | 04/09/12 | New 60,000 Square Foot Lease at the Pacific Research Center Signed by Biomed Realty and Depomed|
SAN DIEGO, April 9, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new ten-year lease with Depomed, Inc. (NASDAQ: DEPO) at its Pacific Research Center campus in Newark, California. Depomed, a specialty pharmaceutical company, leased approximately 60,000 square feet of space at Pacific Research Center North on BioMed Realty's multi-tenant Pacific Research Center campus.
Commenting on their relocation to the Pacific Research Center, Jim Schoeneck, ... |
| | | 04/03/12 | BioMed Realty Trust Completes $400 Million Senior Unsecured Term Loan Financing|
SAN DIEGO, April 3, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that the company has closed a new $400 million senior unsecured term loan facility. The new facility matures on March 30, 2017. The interest rate paid on drawings under the new facility is currently set at LIBOR plus 1.65%, subject to adjustments based on BioMed's credit ratings. The company used the proceeds from this new facility to repay a portion of the outstanding indebtedness under its unsecur... |
| | | 03/15/12 | Biomed Realty Trust Declares First Quarter 2012 Common Stock and Preferred Stock Dividends| Increases common stock dividend by 7.5%
SAN DIEGO, March 15, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a first quarter 2012 dividend of $0.215 per share of common stock, representing a 7.5% increase over the company's fourth quarter 2011 dividend of $0.20 per share. The dividend is equivalent to an annualized dividend of $0.86 per common share.
BioMed also announced that its board of directors has dec... |
| | | 03/13/12 | BioMed Realty Trust to Present at Citi 2012 Global Property CEO Conference|
SAN DIEGO, March 13, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at the Citi 2012 Global Property CEO Conference in Palm Beach, Florida at approximately 10:10 a.m. Eastern Daylight Time on Wednesday, March 14, 2012.
The presentation will be open to all investors by calling 877-211-0500 (domestic) or 201-984-1145 (international) and providing the passcode 6043504.
About BioMed Realty Trust
... |
| | | 03/07/12 | BioMed Realty Signs New Long Term 220,000 Square Foot Lease at the Pacific Research Center|
SAN DIEGO, March 7, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new long term lease with a private biotech company for 220,000 square feet of space at BioMed Realty's multi-tenant Pacific Research Center campus in San Francisco's East Bay.
Alan D. Gold, Chairman and Chief Executive Officer of BioMed Realty, said, "We welcome this new biotech company to the Pacific Research Center community, which will join nine other companies ... |
| | | 03/05/12 | BioMed Realty Trust to Present at the Raymond James 33rd Annual Institutional Investors Conference|
SAN DIEGO, March 5, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today that members of its executive management will present at the Raymond James 33rd Annual Institutional Investors Conference in Orlando, Florida at approximately 1:05 p.m. Eastern Standard Time on Tuesday, March 6, 2012.
A live webcast of the presentation will be available to all investors by accessing the company's website at www.biomedrealty.com. The complete webcast will be archived for 30 days.... |
| | | 02/08/12 | BioMed Realty Trust Reports Fourth Quarter and Full-Year 2011 Financial Results| Generates Five-Quarter Leasing Volume of 2,000,000 Square Feet; Total Assets and Total Revenues Up 12% and 14% Over 2010, Respectively
SAN DIEGO, Feb. 8, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR), a real estate investment trust focused on Providing Real Estate to the Life Science Industry®, today announced financial results for the fourth quarter and full-year ended December 31, 2011.
Fourth Quarter 2011 Highlights
Generated total revenues for the quarter of $112.4 mi... |
| | | 02/06/12 | BioMed Realty Trust to Acquire Cambridge Place For $119 Million |
Acquisition will expand total Boston/Cambridge, Massachusetts portfolio to approximately 3.2 million square feet
SAN DIEGO, Feb. 6, 2012 - PRNewswire via COMTEX - BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has entered into a definitive agreement to acquire Cambridge Place, comprising three buildings and a total of approximately 287,000 square feet of space in Cambridge, Massachusetts. In aggregate, the property is approximately 80% leased, principally to CDM Smith, Inc.,... |
| | | 02/01/12 | BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle|
SAN DIEGO, Feb. 1, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) announced today the signing of a new 15-year lease with Omeros Corporation (NASDAQ: OMER) for BioMed's Waterfront Research Center property located in Seattle, Washington. A clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, coagulopathies and disorders of the central nervous system, Omeros will relocate and consolidate their corporate h... |
| | | 01/31/12 | BioMed Realty Trust to Report 2011 Fourth Quarter and Year End Results|
SAN DIEGO, Jan. 31, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended December 31, 2011 after the market closes on Wednesday, February 8, 2012.
Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President, Matt McDevitt, Executive Vice President, and Greg N. Lubushkin, Chief Financial Officer, will host an investor conference call at 10:00 a.m. Pacific Time on Thursday, February 9, 2012 t... |
| | | 01/17/12 | BioMed Realty Trust Announces Tax Treatment of 2011 Distributions|
SAN DIEGO, Jan. 17, 2012 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE:BMR) today announced the tax treatment of its 2011 distributions as follows:
Security Description: Common Stock
CUSIP: 09063H107
Ticker Symbol: BMR
Record Date
Payable Date
Total Distribution
Per Share
Allocable to 2011
Taxable Ordinary Dividend
Return of Capital
Long-Term Capital Gain
Unrecaptured Section 1250 Gain
12/31/2... |
| |
|
Print | 
E-mail Page | 
RSS Feeds | 
Contacts
